Medicare Enrolled
Dr. Ashokkumar Ghadia, M.D.
Family Medicine · Bakersfield, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ghadia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ghadia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ghadia
Dr. Ashokkumar Ghadia is a family medicine specialist in Bakersfield, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ghadia performed 2,421 Medicare services across 1,362 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ghadia received a total of $14,200 from 71 pharmaceutical and/or device companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ghadia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in CA
$14,200 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,421
Medicare services
Top 8% in CA for family medicine
1,362
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~127 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
873 | $59 | $154 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
432 | $89 | $226 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
256 | $1 | $20 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
161 | $10 | $44 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
101 | $32 | $60 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
91 | $0 | $5 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
90 | $75 | $82 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
79 | $9 | $36 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
59 | $133 | $247 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
58 | $3 | $20 |
| Annual alcohol misuse screening, 5 to 15 minutes | 56 | $19 | $40 |
| Annual depression screening | 55 | $19 | $39 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
35 | $50 | $200 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
34 | $282 | $550 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
28 | $32 | $59 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
13 | $33 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,200
Total received (2018-2024)
Avg $2,029/year across 7 years
Top 3% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
733
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,200 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,061
2023
$2,167
2022
$1,907
2021
$2,297
2020
$1,625
2019
$2,290
2018
$1,853
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$416
GlaxoSmithKline, LLC.
$231
Lilly USA, LLC
$199
PFIZER INC.
$198
IRONSHORE PHARMACEUTICALS INC.
$186
ABBVIE INC.
$164
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Novo Nordisk Inc
$90
Amgen Inc.
$58
Astellas Pharma US Inc
$37
Agile Therapeutics, Inc.
$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$33
Baxter Healthcare
$31
Exact Sciences Corporation
$25
Hologic Sales and Service, LLC
$25
VERTEX PHARMACEUTICALS INCORPORATED
$20
Cranial Technologies, Inc
$19
Agios Pharmaceuticals, Inc.
$19
Abbott Laboratories
$19
Merck Sharp & Dohme LLC
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Phathom Pharmaceuticals, Inc.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Ultragenyx Pharmaceutical Inc.
$15
Medtronic, Inc.
$15
Top 3 companies account for 41.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,207
AstraZeneca Pharmaceuticals LP
$1,898
Boehringer Ingelheim Pharmaceuticals, Inc.
$812
Lilly USA, LLC
$756
Janssen Pharmaceuticals, Inc
$693
PFIZER INC.
$640
Novo Nordisk Inc
$579
Takeda Pharmaceuticals U.S.A., Inc.
$543
Amgen Inc.
$542
ABBVIE INC.
$520
Amarin Pharma Inc.
$509
Merck Sharp & Dohme Corporation
$418
Biohaven Pharmaceuticals, Inc.
$284
Biohaven Pharmaceutical Holding Company Ltd.
$252
AbbVie Inc.
$249
Abbott Laboratories
$189
Ironshore Pharmaceuticals Inc.
$187
IRONSHORE PHARMACEUTICALS INC.
$186
Astellas Pharma US Inc
$165
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$155
Avanir Pharmaceuticals, Inc.
$151
Bayer Healthcare Pharmaceuticals Inc.
$135
Agile Therapeutics, Inc.
$130
Bayer HealthCare Pharmaceuticals Inc.
$120
Allergan, Inc.
$116
Pulmonx Corporation
$113
SANOFI-AVENTIS U.S. LLC
$109
AbbVie, Inc.
$104
Exact Sciences Corporation
$92
AngioDynamics, Inc.
$91
Eisai Inc.
$85
Vanda Pharmaceuticals Inc.
$73
Otsuka America Pharmaceutical, Inc.
$71
Merck Sharp & Dohme LLC
$71
Nevro Corp.
$52
Daiichi Sankyo Inc.
$52
Medtronic, Inc.
$47
Ironwood Pharmaceuticals, Inc
$44
Allergan Inc.
$43
Relypsa, Inc.
$40
SANOFI PASTEUR INC.
$39
Shire North American Group Inc
$38
Corcept Therapeutics
$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$33
Baxter Healthcare
$31
Lundbeck LLC
$31
Corium, LLC
$30
Avadel Specialty Pharmaceuticals, LLC
$28
SCILEX PHARMACEUTICALS INC.
$26
IRONWOOD PHARMACEUTICALS, INC
$26
Esperion Therapeutics, Inc.
$25
Hologic Sales and Service, LLC
$25
Nestle HealthCare Nutrition Inc.
$23
E.R. Squibb & Sons, L.L.C.
$20
VERTEX PHARMACEUTICALS INCORPORATED
$20
Cranial Technologies, Inc
$19
Agios Pharmaceuticals, Inc.
$19
VBI Vaccines (Delaware) Inc.
$19
Horizon Therapeutics plc
$18
ITI, Inc.
$18
Phathom Pharmaceuticals, Inc.
$17
Novartis Pharmaceuticals Corporation
$17
Ultragenyx Pharmaceutical Inc.
$15
Phadia US Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Boston Scientific Corporation
$13
Almatica Pharma LLC
$13
Axsome Therapeutics, Inc.
$13
Horizon Pharma plc
$12
Alkermes, Inc.
$12
Zyla Life Sciences
$12
Top 3 companies account for 34.6% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · AREXVY · ARISTADA · ASSURITY · AZSTARYS · Aimovig · Amitiza · Androgel · Assurity Pacemaker · Auryon Laser System 100-120 Vac · Auvelity · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · CAPLYTA · CARDIOMEMS · CHANTIX · CREON · Cologuard Collection Kit · Crysvita · DUEXIS · Dayvigo · Doc Band · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Ellipse ICD · Evekeo · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT · FREESTYLE LIBRE 2 · Fortify Assura · GARDASIL · GARDASIL 9 · GENERAL PAIN MANAGEMENT · GRALISE · HETLIOZ · Hillrom - Monarch Airway Clearance System · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JORNAY PM · Kerendia · Korlym · LINZESS · LYRICA · Linzess · MOTEGRITY · MOUNJARO · MYRBETRIQ · Merlin Connectivity and Remote · Motegrity · NATPARA · NEXLETOL · NUEDEXTA · NURTEC ODT · Noctiva · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREVNAR 13 · PYRUKYND · PreHevbrio · Prolia · Pulmonx Endobronchial Valve EBV · QULIPTA · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPRIX · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Senza · Synthroid · THINPREP 2000 PROCESSOR · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Twirla · UBRELVY · VAXELIS · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veltassa · Veozah · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · ZENPEP · ZEPBOUND · ZOSTAVAX · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
169
Per 100K population
18.6
County median income
$67,660
Nearest hospital
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
14.3 mi
14.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ghadia is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 3% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ghadia experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ghadia performed 873 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ghadia receive payments from pharmaceutical companies?
Yes. Dr. Ghadia received a total of $14,200 from 71 companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ghadia's costs compare to other family medicine physicians in Bakersfield?
Dr. Ghadia's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ghadia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Bakersfield
Browse family medicine physicians in Bakersfield ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology